 Kim Williams
Concepts (219)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiology | 19 | 2019 | 102 | 5.630 |
Why?
| | Cardiovascular Diseases | 14 | 2021 | 410 | 4.810 |
Why?
| | Advisory Committees | 9 | 2019 | 48 | 2.260 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 7 | 2017 | 84 | 2.170 |
Why?
| | Myocardial Perfusion Imaging | 9 | 2020 | 63 | 2.150 |
Why?
| | Delivery of Health Care | 4 | 2016 | 130 | 2.100 |
Why?
| | Societies, Medical | 5 | 2015 | 209 | 2.100 |
Why?
| | United States | 27 | 2021 | 2539 | 1.810 |
Why?
| | Hypertension | 9 | 2019 | 283 | 1.690 |
Why?
| | Practice Guidelines as Topic | 9 | 2019 | 389 | 1.550 |
Why?
| | Coronary Disease | 5 | 2017 | 98 | 1.540 |
Why?
| | Blood Pressure | 7 | 2019 | 260 | 1.470 |
Why?
| | Medicare | 4 | 2020 | 113 | 1.390 |
Why?
| | American Heart Association | 9 | 2019 | 39 | 1.280 |
Why?
| | Coronary Artery Disease | 7 | 2020 | 159 | 1.240 |
Why?
| | Primary Prevention | 6 | 2021 | 53 | 1.230 |
Why?
| | Leadership | 3 | 2016 | 109 | 1.210 |
Why?
| | Humans | 55 | 2021 | 31481 | 1.170 |
Why?
| | Specialty Boards | 2 | 2015 | 10 | 1.160 |
Why?
| | Patient Advocacy | 2 | 2015 | 17 | 1.150 |
Why?
| | Unnecessary Procedures | 2 | 2016 | 30 | 1.140 |
Why?
| | Health Care Costs | 2 | 2016 | 81 | 1.120 |
Why?
| | Certification | 2 | 2015 | 60 | 1.100 |
Why?
| | Heart Diseases | 2 | 2018 | 102 | 1.010 |
Why?
| | Diet | 3 | 2021 | 202 | 0.940 |
Why?
| | Research Report | 4 | 2019 | 11 | 0.910 |
Why?
| | Early Medical Intervention | 1 | 2021 | 18 | 0.890 |
Why?
| | Eating | 1 | 2021 | 61 | 0.850 |
Why?
| | Hernias, Diaphragmatic, Congenital | 1 | 2020 | 5 | 0.830 |
Why?
| | Myocardium | 2 | 2018 | 183 | 0.800 |
Why?
| | Social Class | 4 | 2020 | 71 | 0.800 |
Why?
| | Coronary Angiography | 3 | 2018 | 106 | 0.790 |
Why?
| | Tomography, X-Ray Computed | 3 | 2017 | 891 | 0.790 |
Why?
| | Nutritional Sciences | 1 | 2018 | 13 | 0.730 |
Why?
| | Public Health | 2 | 2016 | 66 | 0.730 |
Why?
| | Coronary Circulation | 1 | 2018 | 49 | 0.730 |
Why?
| | Quality Assurance, Health Care | 2 | 2016 | 54 | 0.720 |
Why?
| | Life Expectancy | 1 | 2018 | 22 | 0.700 |
Why?
| | Medicaid | 2 | 2015 | 43 | 0.690 |
Why?
| | Fruit | 1 | 2017 | 20 | 0.670 |
Why?
| | Vegetables | 1 | 2017 | 22 | 0.670 |
Why?
| | Healthcare Disparities | 3 | 2020 | 82 | 0.670 |
Why?
| | Chest Pain | 1 | 2017 | 23 | 0.660 |
Why?
| | Aneurysm, Dissecting | 1 | 2017 | 21 | 0.650 |
Why?
| | Heart Failure | 2 | 2018 | 232 | 0.650 |
Why?
| | Quality Improvement | 2 | 2016 | 173 | 0.650 |
Why?
| | Drug Prescriptions | 2 | 2017 | 37 | 0.650 |
Why?
| | Antihypertensive Agents | 4 | 2019 | 91 | 0.640 |
Why?
| | African Americans | 3 | 2021 | 818 | 0.620 |
Why?
| | Disease Management | 4 | 2017 | 147 | 0.610 |
Why?
| | Neoplasms, Radiation-Induced | 1 | 2016 | 18 | 0.600 |
Why?
| | Government Regulation | 1 | 2015 | 8 | 0.600 |
Why?
| | Medical Errors | 1 | 2016 | 31 | 0.590 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 81 | 0.590 |
Why?
| | Public-Private Sector Partnerships | 1 | 2015 | 5 | 0.590 |
Why?
| | Diagnostic Errors | 1 | 2016 | 48 | 0.590 |
Why?
| | Anniversaries and Special Events | 1 | 2015 | 4 | 0.590 |
Why?
| | Cholesterol, Dietary | 1 | 2015 | 4 | 0.590 |
Why?
| | Nutrition Policy | 1 | 2015 | 12 | 0.590 |
Why?
| | Program Development | 1 | 2016 | 76 | 0.590 |
Why?
| | Internal Medicine | 1 | 2015 | 34 | 0.580 |
Why?
| | Insurance Carriers | 1 | 2015 | 3 | 0.570 |
Why?
| | Patient Discharge | 1 | 2017 | 163 | 0.570 |
Why?
| | Cardiomyopathies | 1 | 2015 | 39 | 0.550 |
Why?
| | Myocardial Infarction | 1 | 2016 | 187 | 0.540 |
Why?
| | Hospitals, Urban | 1 | 2014 | 37 | 0.540 |
Why?
| | Risk Factors | 11 | 2021 | 2664 | 0.500 |
Why?
| | Radiography, Thoracic | 1 | 2013 | 39 | 0.490 |
Why?
| | Patient Readmission | 1 | 2014 | 129 | 0.490 |
Why?
| | Calcinosis | 1 | 2013 | 53 | 0.480 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2015 | 224 | 0.460 |
Why?
| | Aged | 12 | 2021 | 10295 | 0.440 |
Why?
| | Technetium Tc 99m Sestamibi | 1 | 2010 | 12 | 0.420 |
Why?
| | Diagnostic Imaging | 1 | 2011 | 98 | 0.410 |
Why?
| | Radiopharmaceuticals | 1 | 2010 | 63 | 0.400 |
Why?
| | Female | 16 | 2021 | 18253 | 0.380 |
Why?
| | Aging | 1 | 2019 | 1614 | 0.380 |
Why?
| | Middle Aged | 12 | 2021 | 11209 | 0.370 |
Why?
| | Risk Assessment | 7 | 2021 | 806 | 0.370 |
Why?
| | Male | 13 | 2021 | 17583 | 0.350 |
Why?
| | Myocardial Ischemia | 2 | 2018 | 63 | 0.320 |
Why?
| | Medical Oncology | 2 | 2018 | 39 | 0.310 |
Why?
| | Organizational Objectives | 2 | 2015 | 25 | 0.290 |
Why?
| | Prognosis | 4 | 2021 | 1028 | 0.280 |
Why?
| | Cardiac Imaging Techniques | 2 | 2017 | 8 | 0.280 |
Why?
| | Aged, 80 and over | 5 | 2020 | 5234 | 0.270 |
Why?
| | Comorbidity | 4 | 2021 | 562 | 0.250 |
Why?
| | Incidence | 3 | 2016 | 829 | 0.250 |
Why?
| | Adult | 8 | 2017 | 9779 | 0.250 |
Why?
| | Retrospective Studies | 6 | 2021 | 3591 | 0.240 |
Why?
| | Risk Reduction Behavior | 2 | 2019 | 59 | 0.230 |
Why?
| | Prospective Studies | 3 | 2017 | 1934 | 0.230 |
Why?
| | Troponin | 1 | 2021 | 11 | 0.220 |
Why?
| | Age Factors | 3 | 2020 | 943 | 0.220 |
Why?
| | Randomized Controlled Trials as Topic | 3 | 2018 | 375 | 0.220 |
Why?
| | Guidelines as Topic | 1 | 2021 | 79 | 0.210 |
Why?
| | Evidence-Based Medicine | 3 | 2018 | 239 | 0.210 |
Why?
| | Genetic Predisposition to Disease | 2 | 2014 | 462 | 0.210 |
Why?
| | Cohort Studies | 2 | 2017 | 2014 | 0.200 |
Why?
| | Social Determinants of Health | 1 | 2020 | 22 | 0.200 |
Why?
| | Sex Characteristics | 1 | 2021 | 128 | 0.200 |
Why?
| | Quality Indicators, Health Care | 1 | 2020 | 43 | 0.190 |
Why?
| | Treatment Outcome | 5 | 2020 | 3910 | 0.190 |
Why?
| | Ambulatory Care | 1 | 2020 | 90 | 0.190 |
Why?
| | Preventive Medicine | 1 | 2018 | 13 | 0.180 |
Why?
| | Plaque, Atherosclerotic | 1 | 2018 | 21 | 0.180 |
Why?
| | Cholesterol | 1 | 2018 | 68 | 0.180 |
Why?
| | Thymoma | 1 | 2017 | 15 | 0.170 |
Why?
| | Mediastinal Neoplasms | 1 | 2017 | 15 | 0.170 |
Why?
| | Health Status | 1 | 2019 | 249 | 0.170 |
Why?
| | Prevalence | 3 | 2016 | 544 | 0.170 |
Why?
| | Diet, Vegetarian | 1 | 2017 | 2 | 0.170 |
Why?
| | Cultural Diversity | 1 | 2017 | 31 | 0.160 |
Why?
| | Diabetes Mellitus | 1 | 2018 | 150 | 0.160 |
Why?
| | Predictive Value of Tests | 3 | 2017 | 637 | 0.160 |
Why?
| | Cholesterol, LDL | 2 | 2016 | 46 | 0.160 |
Why?
| | Socioeconomic Factors | 1 | 2018 | 362 | 0.150 |
Why?
| | Radiation Protection | 1 | 2016 | 8 | 0.150 |
Why?
| | Causality | 1 | 2016 | 58 | 0.150 |
Why?
| | Lipoprotein(a) | 1 | 2016 | 10 | 0.150 |
Why?
| | Value-Based Purchasing | 1 | 2015 | 2 | 0.150 |
Why?
| | Physician Incentive Plans | 1 | 2015 | 3 | 0.150 |
Why?
| | Time Factors | 4 | 2021 | 1902 | 0.150 |
Why?
| | Sex Distribution | 1 | 2016 | 89 | 0.150 |
Why?
| | Age Distribution | 1 | 2016 | 110 | 0.150 |
Why?
| | Organizational Innovation | 1 | 2015 | 21 | 0.150 |
Why?
| | Dyslipidemias | 1 | 2016 | 26 | 0.150 |
Why?
| | Cardiology Service, Hospital | 1 | 2015 | 3 | 0.150 |
Why?
| | Diagnosis, Differential | 1 | 2017 | 467 | 0.150 |
Why?
| | Chicago | 2 | 2016 | 955 | 0.150 |
Why?
| | Oncology Service, Hospital | 1 | 2015 | 4 | 0.150 |
Why?
| | Public Relations | 1 | 2015 | 3 | 0.150 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2017 | 512 | 0.150 |
Why?
| | Anticoagulants | 1 | 2016 | 151 | 0.140 |
Why?
| | Obesity | 1 | 2018 | 338 | 0.140 |
Why?
| | Cross-Sectional Studies | 2 | 2016 | 986 | 0.140 |
Why?
| | Michigan | 1 | 2014 | 21 | 0.140 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2014 | 28 | 0.140 |
Why?
| | Survival Rate | 1 | 2016 | 465 | 0.140 |
Why?
| | Patient Protection and Affordable Care Act | 1 | 2014 | 26 | 0.130 |
Why?
| | Academic Medical Centers | 1 | 2015 | 158 | 0.130 |
Why?
| | Fractional Flow Reserve, Myocardial | 1 | 2013 | 2 | 0.130 |
Why?
| | Physicians | 1 | 2015 | 120 | 0.130 |
Why?
| | Cardiac-Gated Imaging Techniques | 1 | 2013 | 2 | 0.130 |
Why?
| | Atrial Fibrillation | 1 | 2016 | 197 | 0.130 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2016 | 230 | 0.120 |
Why?
| | Chi-Square Distribution | 1 | 2013 | 178 | 0.120 |
Why?
| | Genetic Markers | 1 | 2012 | 51 | 0.120 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2014 | 332 | 0.120 |
Why?
| | Stroke | 1 | 2016 | 367 | 0.120 |
Why?
| | Polymorphism, Genetic | 1 | 2012 | 87 | 0.120 |
Why?
| | Contrast Media | 1 | 2013 | 144 | 0.120 |
Why?
| | Young Adult | 2 | 2016 | 2277 | 0.110 |
Why?
| | Sensitivity and Specificity | 1 | 2013 | 580 | 0.110 |
Why?
| | Radiation Dosage | 1 | 2011 | 35 | 0.110 |
Why?
| | Risk | 1 | 2011 | 228 | 0.100 |
Why?
| | Adenosine | 1 | 2010 | 15 | 0.100 |
Why?
| | Vasodilator Agents | 1 | 2010 | 34 | 0.100 |
Why?
| | Illinois | 2 | 2021 | 266 | 0.100 |
Why?
| | Hospital Mortality | 2 | 2021 | 192 | 0.100 |
Why?
| | Exercise Test | 1 | 2010 | 123 | 0.090 |
Why?
| | Consensus | 2 | 2018 | 106 | 0.090 |
Why?
| | Up-Regulation | 2 | 2021 | 220 | 0.080 |
Why?
| | Disease Progression | 1 | 2010 | 861 | 0.080 |
Why?
| | Positron-Emission Tomography | 2 | 2017 | 95 | 0.070 |
Why?
| | Rural Health Services | 1 | 2005 | 6 | 0.070 |
Why?
| | Health Services for the Aged | 1 | 2005 | 11 | 0.070 |
Why?
| | Sex Factors | 2 | 2017 | 542 | 0.070 |
Why?
| | Health Services Accessibility | 1 | 2005 | 113 | 0.060 |
Why?
| | Severity of Illness Index | 2 | 2021 | 1240 | 0.060 |
Why?
| | Patient Satisfaction | 1 | 2005 | 315 | 0.050 |
Why?
| | Fee-for-Service Plans | 1 | 2020 | 5 | 0.050 |
Why?
| | Registries | 1 | 2020 | 214 | 0.040 |
Why?
| | Interdisciplinary Communication | 1 | 2018 | 31 | 0.040 |
Why?
| | Intensive Care Units | 1 | 2021 | 316 | 0.040 |
Why?
| | Organophosphorus Compounds | 1 | 2017 | 7 | 0.040 |
Why?
| | Organotechnetium Compounds | 1 | 2017 | 9 | 0.040 |
Why?
| | Incidental Findings | 1 | 2017 | 20 | 0.040 |
Why?
| | Hospitalization | 1 | 2021 | 359 | 0.040 |
Why?
| | Tissue Survival | 1 | 2017 | 3 | 0.040 |
Why?
| | Multidetector Computed Tomography | 1 | 2017 | 12 | 0.040 |
Why?
| | Pyridones | 1 | 2016 | 19 | 0.040 |
Why?
| | Thiazoles | 1 | 2016 | 38 | 0.040 |
Why?
| | Pyridines | 1 | 2016 | 50 | 0.040 |
Why?
| | Administration, Oral | 1 | 2016 | 164 | 0.040 |
Why?
| | Echocardiography | 1 | 2017 | 197 | 0.040 |
Why?
| | Georgia | 1 | 2016 | 16 | 0.040 |
Why?
| | Hemorrhage | 1 | 2016 | 90 | 0.040 |
Why?
| | Warfarin | 1 | 2016 | 60 | 0.040 |
Why?
| | Pyrazoles | 1 | 2016 | 55 | 0.040 |
Why?
| | Odds Ratio | 1 | 2016 | 327 | 0.040 |
Why?
| | Meta-Analysis as Topic | 1 | 2014 | 43 | 0.030 |
Why?
| | Gene Frequency | 1 | 2014 | 80 | 0.030 |
Why?
| | Blood Flow Velocity | 1 | 2013 | 26 | 0.030 |
Why?
| | Myocardial Revascularization | 1 | 2013 | 25 | 0.030 |
Why?
| | Models, Cardiovascular | 1 | 2013 | 23 | 0.030 |
Why?
| | Coronary Stenosis | 1 | 2013 | 17 | 0.030 |
Why?
| | Electrocardiography | 1 | 2014 | 209 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2014 | 390 | 0.030 |
Why?
| | Models, Animal | 1 | 2013 | 149 | 0.030 |
Why?
| | Regression Analysis | 1 | 2014 | 319 | 0.030 |
Why?
| | Mendelian Randomization Analysis | 1 | 2012 | 8 | 0.030 |
Why?
| | Genome-Wide Association Study | 1 | 2014 | 315 | 0.030 |
Why?
| | Global Health | 1 | 2012 | 60 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 1 | 2017 | 1273 | 0.030 |
Why?
| | Clinical Trials as Topic | 1 | 2013 | 378 | 0.030 |
Why?
| | Decision Making | 1 | 2013 | 232 | 0.030 |
Why?
| | Child | 1 | 2014 | 1572 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2012 | 2028 | 0.020 |
Why?
| | Adolescent | 1 | 2014 | 2667 | 0.020 |
Why?
| | West Virginia | 1 | 2005 | 2 | 0.020 |
Why?
| | Transportation | 1 | 2005 | 6 | 0.020 |
Why?
| | Social Isolation | 1 | 2005 | 26 | 0.020 |
Why?
| | Financing, Personal | 1 | 2005 | 24 | 0.020 |
Why?
| | Focus Groups | 1 | 2005 | 93 | 0.020 |
Why?
| | Physician-Patient Relations | 1 | 2005 | 47 | 0.020 |
Why?
| | Interviews as Topic | 1 | 2005 | 152 | 0.020 |
Why?
| | Animals | 1 | 2013 | 5312 | 0.020 |
Why?
| | Quality of Health Care | 1 | 2005 | 141 | 0.020 |
Why?
|
|
Williams's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|